We conclude that women with RPL without APS, uterine anomaly or chromosome abnormality have a high probability of live birth following a positive pregnancy test, being similar between those with positive and negative ANA testing, regardless of the cut-off value and that measurement of ANA is not necessary in women with RPL to predict next pregnancy prognosis. This evidence concerns the gene BTG3 and autoimmune polyendocrinopathy.